Childhood obesity and allergic rhinitis: A meta-analysis

Xinxin Xing1, Sihao Zhu1, Guang Zhou1

  • 1Department of Pediatrics II, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Biomolecules & Biomedicine
|September 24, 2025
PubMed

Insights

Childhood obesity is not significantly linked to allergic rhinitis (AR) overall. However, a potential association exists in Western countries and with specific diagnostic criteria, warranting further investigation.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health and Epidemiology
  • Obesity Research

Background:

  • Allergic rhinitis (AR) is a common childhood condition with increasing prevalence.
  • Obesity is a growing public health concern in children.
  • Research is exploring potential links between modifiable factors like obesity and AR incidence.

Purpose of the Study:

  • To conduct a meta-analysis assessing the multivariate-adjusted relationship between childhood obesity and allergic rhinitis.
  • To synthesize evidence from observational studies on this association.

Main Methods:

  • Systematic literature search across PubMed, Embase, and Web of Science.
  • Inclusion of observational studies with multivariate adjustments for age and sex.
  • Random-effects models used to pool odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

  • Analysis of 15 cross-sectional studies (569,856 children) found no overall significant association between childhood obesity and AR (aOR: 1.04, 95% CI: 1.00-1.09).
  • Subgroup analyses revealed a significant association in Western countries (OR: 1.12, 95% CI: 1.00-1.24) but not in Asian countries (OR: 1.04, 95% CI: 0.97-1.12).
  • Significant associations were noted with national/international BMI cutoffs and physician-diagnosed AR, but not with 95th percentile BMI or ISAAC-based diagnosis.

Conclusions:

  • While the overall link between childhood obesity and AR is not statistically significant, subgroup findings suggest potential associations in specific geographic regions and diagnostic contexts.
  • These results highlight the importance of considering methodological variations in defining obesity and AR.
  • Further longitudinal research is recommended to clarify the relationship and inform preventive strategies for both conditions.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Allergic Reactions02:06

Allergic Reactions

Overview
32.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K